BALAXI Overseas Pvt� LIMITED�has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BALAXI Pharmaceuticals has informed the exchange that its promoter group entity, Balaxi Overseas Pvt Limited, has submitted a disclosure under Regulation 31(4) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. This regulation requires promoters to report details of shares they have pledged or otherwise encumbered. The headline does not include specific numbers on the quantity of shares pledged, released, or invoked, nor the current pledge percentage. Investors would need to view the actual disclosure document on the NSE/BSE portal to know the exact details of the encumbrance position.
The bare submission of a Reg 31(4) disclosure by itself is a procedural compliance update and not an immediate positive or negative trigger. Shareholders should review the linked disclosure to check whether pledge levels have changed materially, as high or rising promoter pledges can be a risk signal for the stock.